Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Isomerization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic hydrogenation method for tranexamic acid. Reduces catalyst poisoning, improves trans-isomer ratio, ensures supply chain stability for pharmaceutical intermediates.
Patent CN112321638A reveals a mild Si-H reduction route for dialkyl phosphinates, offering high purity and cost reduction in flame retardant manufacturing.
Novel non-metal catalytic synthesis for 1,2-dihydropyridine derivatives. High atom economy, green process, reliable supply chain for pharmaceutical intermediates.
Patent CN116969812B reveals LED-driven isohexide isomerization enhancing Z-selectivity for vitamin A synthesis with reduced coking and safer operational conditions for supply chains.
Patent CN105585470B reveals green fructose-to-MCP route. Enhances supply chain stability and reduces environmental impact for flavor manufacturers.
Patent CN111233605A reveals a efficient two-step route for trans-4-alkyl-4'-alkyl-1,1'-bicyclohexane, offering significant cost reduction and purity advantages for electronic chemical manufacturing.
Patent CN103172528B details a high-efficiency tranexamic acid method. It offers significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Advanced Suzuki coupling and hydrogenation route for high-purity trans-ketone intermediates. Reduces impurities and simplifies purification for LCD manufacturers.
Novel Ru/C catalyzed hydrogenation and solvent-free isomerization route for high-purity liquid crystal intermediates with over 90% yield.
Patent CN108752178B reveals a high-yield Grignard-based route for decarene aldehyde, offering significant cost reduction and supply chain stability for carotenoid manufacturers.
Patent CN101903366B details a novel ruthenium-catalyzed hydrogenation and isomerization process for producing high-purity cis-rose oxide, offering significant cost and supply chain advantages.
Patent CN110143875B reveals a high-yield route for Vitamin A intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.